December 4, 2006
Clinical Trial Litigation
The WSJ Law Blog has a good rundown of the potential exposure to Pfizer relating to the shutdown of clinical trials on its HDL-elevating drug Torcetrapib. As you'd expect, there's both potential tort litigation (though the clinical trial releases are likely broad enough to protect against most of that) and securities litigation.
Update: FDA has its press release up.
TrackBack URL for this entry:
Listed below are links to weblogs that reference Clinical Trial Litigation:
I'm implementing values-based issues management in Georgia to change the nature of public discourse on tort reform and other attacks on the legal system (in other words, make them care about civil justice, when studies show they don't) with good results. Check out the website I just launched for Georgia Civil Justice Foundation at www.fairplay.org. Feedback encouraged: firstname.lastname@example.org.
Posted by: Nina Mason | Dec 5, 2006 1:35:03 PM